Original Research

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer

Wang H, Chu J, Zhao Y, Tang H, Wang L, Zhou M, Yan Z, Liu Y, Yao Z

Cancer Management and Research 2020, 12:3827-3834

Published Date: 22 May 2020